Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer

NCT02785068 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: MM-151
DRUG: nal-IRI
DRUG: Leucovorin
DRUG: 5-FU

Sponsor

Merrimack Pharmaceuticals